In this issue of Healthcare Matters, we are pleased to feature Levabo as our Nursing & Care Company of the Month.
Levabo was founded in 2014 by Peter Egelund with a clear and ambitious vision: to help eliminate pressure ulcers through prevention rather than treatment. This founding philosophy still underpins everything the company does today. Recognising both the human and economic cost of pressure injuries, Levabo was built on the belief that better positioning, smarter support surfaces, and closer collaboration with care providers could significantly reduce their occurrence.
Headquartered in Skanderborg, Denmark, Levabo has grown into an international organisation. In addition to its Danish base, the company operates a subsidiary in Hong Kong and is represented across key European markets, including the UK and Germany, through dedicated country managers. Continuing its global expansion, Levabo is also preparing to open an office in the United States, marking an important milestone in its international growth strategy.
At its core, Levabo focuses on the prevention of pressure injuries and ulcers. The company develops and supplies individualised positioning solutions designed in close collaboration with healthcare professionals. This approach ensures that products are not only clinically effective but also practical and intuitive for everyday use in care environments. By incorporating feedback from frontline caregivers, Levabo ensures its solutions address real-world challenges faced in hospitals, care homes, and home care settings.
Within the industry, Levabo positions itself at the forefront of preventive and supportive positioning solutions. The company has been recognised globally for its innovation and quality, being awarded ‘Best Positioning Cushions Manufacturer’ for four consecutive years from 2023 to 2026. This consistent recognition reflects both the strength of its product portfolio and its commitment to improving patient outcomes.
A key differentiator for Levabo is its unique ‘Fluffy Air’ technology. This design principle ensures that products remain soft, adaptable, and responsive to the patient’s body shape. Unlike more rigid alternatives, Levabo’s solutions distribute pressure more effectively while maintaining comfort, making them particularly suited for long-term use in vulnerable patient groups.
Levabo’s products are widely used across hospitals, clinics, and care homes, as well as in private home care settings where individuals require specialist positioning support. This broad reach reflects the universal need for effective pressure ulcer prevention across all levels of care.
Guided by the tagline ‘Simple products – big impact,’ Levabo emphasises ease of use alongside clinical effectiveness. The company believes that solutions should not add complexity to care but instead simplify processes while delivering meaningful improvements in patient safety and comfort.
Recent developments include the company’s planned expansion into the US market in 2026, further extending its global footprint. Alongside this, Levabo continues to invest in innovation, with many of its products protected by international patents and recognised as best-in-class within the sector.
Looking ahead, Levabo’s goal is clear: to elevate the importance of pressure ulcer prevention across the healthcare agenda. By increasing awareness and promoting proactive strategies, the company aims to shift the focus from treatment to prevention.
For care providers, the message is simple but powerful; pressure ulcers can be prevented, and the cost of prevention is significantly lower than the cost of treatment, both financially and in terms of patient wellbeing.
For more information, please see below:
T +45 31 70 40 25
bm@levabo.com
www.levabo.com